Publications

Laboratory for Molecular Cancer Biology

2024
Text

A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma - Pozniak J, Pedri D, Landeloos E, Van Herck Y, Antoranz A, Vanwynsberghe L, Nowosad A, Roda N, Makhzami S, Bervoets G, Maciel LF, Pulido-Vicuña CA, Pollaris L, Seurinck R, Zhao F, Flem-Karlsen K, Damsky W, Chen L, Karagianni D, Cinque S, Kint S, Vandereyken K, Rombaut B, Voet T, Vernaillen F, Annaert W, Lambrechts D, Boecxstaens V, Saeys Y, van den Oord J, Bosisio F, Karras P, Shain AH, Bosenberg M, Leucci E, Paschen A, Rambow F, Bechter O, Marine JC. - 2024 - Cell - Pubmed

2023
Text

Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy - Talebi A, de Laat V, Spotbeen X, Dehairs J, Rambow F, Rogiers A, Vanderhoydonc F, Rizotto L, Planque M, Doglioni G, Motamedi S, Nittner D, Roskams T, Agostinis P, Bechter O, Boecxstaens V, Garmyn M, O'Farrell M, Wagman A, Kemble G, Leucci E, Fendt SM, Marine JC, Swinnen JV. - 2023 - J Exp Clin Cancer - Pubmed

Perivascular niches: critical hubs in cancer evolution - Nowosad A, Marine JC, Karras P. - 2023 - Trends Cancer - Pubmed

 

2022
Text

A cellular hierarchy in melanoma uncouples growth and metastasis - Karras P, Bordeu I, Pozniak J, Nowosad A, Pazzi C, Van Raemdonck N, Landeloos E, Van Herck Y, Pedri D, Bervoets G, Makhzami S, Khoo JH, Pavie B, Lamote J, Marin-Bejar O, Dewaele M, Liang H, Zhang X, Hua Y, Wouters J, Browaeys R, Bergers G, Saeys Y, Bosisio F, van den Oord J, Lambrechts D, Rustgi AK, Bechter O, Blanpain C, Simons BD, Rambow F, Marine JC - 2022 - Nature - Pubmed

A TCF4/BRD4-dependent regulatory network confers cross-resistance to targeted and immune checkpoint therapy in melanoma -  Pozniak J,  Pedri D, Landeloos E, Van Herck Y,  Antoranz A,  Karras P,  Nowosad A, Makhzami S,  Bervoets G,  Dewaele M,  Vanwynsberghe L, Cinque S, Kint S,  Vandereyken K,  Voet T,  Vernaillen F, Annaert W,  Lambrechts D,  Boecxstaens V, van den Oord J, Bosisio F,  Leucci E, Rambow F, Bechter O,  Marine JC - 2022 - BioRxiv

Treatment for giant congenital nevi moves a step closer - Pozniak J, Marine JC - 2022 - Cell Res. - Pubmed

Cell position matters in tumour development - Marine JC, Soengas MS - 2022 - Nature - Pubmed

2021
Text

Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma - Vendramin R, Katopodi V, Cinque S, Konnova A, Knezevic Z, Adnane S, Verheyden Y, Karras P, Demesmaeker E, Bosisio FM, Kucera L, Rozman J, Gladwyn-Ng I, Rizzotto L, Dassi E, Millevoi S, Bechter O, Marine JC, Leucci E. - J Exp Med. - Pubmed

Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma - Marin-Bejar O, Rogiers A, Dewaele M, Femel J, Karras P, Pozniak J, Bervoets G, Van Raemdonck N, Pedri D, Swings T, Demeulemeester J, Borght SV, Lehnert S, Bosisio F, van den Oord JJ, Bempt IV, Lambrechts D, Voet T, Bechter O, Rizos H, Levesque MP, Leucci E, Lund AW, Rambow F, Marine JC - Cancer Cell - Pubmed

Epithelial-to-mesenchymal-like transition events in melanoma - Pedri D, Karras P, Landeloos E, Marine JC, Rambow F - FEBS J - Pubmed

2020
Text

Integrator restrains paraspeckles assembly by promoting isoform switching of the lncRNA NEAT1 - Barra J, Gaidosh GS, Blumenthal Ezra, Beckedorff F, Tayari MM, Kirstein N, Karakach TK, Heick Jensen T, Impens F, Gevaert K, Leucci E, Shiekhattar R and Marine JC - Science Adv - Pubmed

Non-Genetic Mechanisms of Therapeutic Resistance in Cancer - Marine JC, Dawson SJ and Dawson MA - Nat Rev Cancer - Pubmed

 

2019
Text

Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities - Rambow F, Marine J-C* & Goding C* - Genes & Dev - Pubmed

The lncRNA NEAT1_1 is seemingly dispensable for normal tissue homeostasis and cancer cell growth - Adriaens C, Rambow F, Bervoets G, Silla T, Mito M, Chiba T, Hiroshi A, Hirose T, Nakagawa S, Jensen T and Marine JC - RNA - Pubmed

2018
Text

Toward Minimal Residual Disease-Directed Therapy in Melanoma - Rambow F., Rogiers A, Aibar S, Dewaele M, Marin-Bejar O, Adriaens C, Talebi A, Wouters J, Radaelli E, Wolter P, Bechter O, Piris A, Frederick DT, Boland G, Flaherty KT, van den Oord JJ, Aerts S & Marine JC - 2018 - Cell - Pubmed

Identification of the tumour transition states occurring during EMT - Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Renvenco T, Boumahdi S, Van Keymeulen A, Brown D, Moers V, Lemaire S, de Clercq S, Minguijon-Perez E, Balsat C, Sokolow S, Dubois C, de Cock F, Scozzaro S, Lanas A, D’Haene N, Salmon I, Marine JC, Voet T, Sotiropoulou P & Blanpain C - 2018 - Nature - Pubmed

2017
Text

Mouse Cutaneous Melanoma Induced by Mutant BRaf Arises from Expansion and Dedifferentiation of Mature Pigmented Melanocytes - Köhler C, Nittner D, Rambow F, Radaelli E, Stanchi F, Niels Vandamme N, Baggiolini A, Sommer L, Berx G, van den Oord J, Gerhardt H, Blanpain C & Marine JC - 2017 - Cell Stem Cell - Pubmed

2016
Text

p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity - Adriaens C, Standaert L, Barra J, Latil M, Verfaillie A, Kalev P, Boeckx B, Wijnhoven PW, Radaelli E, Vermi W, Leucci E, Lapouge G, Beck B, van den Oord J, Nakagawa S, Hirose T, Sablina AA, Lambrechts D, Aerts S, Blanpain C, Marine JC - 2016 - Nat Med - Pubmed

Melanoma Addiction to the lncRNA SAMMSON - Leucci E, Vendramin R, Spinazzi M, Laurette P, Fiers M, Wouters J, Radaelli E, Eyckerman S, Leonelli C, Venderheyden K, Rogiers A, Hermans E, Baatsen P, Aerts S, Amant F, Van Aelst S, van den Oord J, de Strooper B, Davidson I, Lafontaine D, Gevaert K, Vandesompele Jo, Mestdagh P, & Marine JC - 2016 - Nature - Pubmed
 

2012
Text

Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation - Nittner D, Lambertz I, Clermont F, Mestdagh P, Köhler C, Nielsen SJ, Jochemsen A, Speleman F, Vandesompele J, Dyer MA, Schramm A, Schulte JH, Marine JC - 2012 - Nat Cell Biol - Pubmed

MDM4 is a key therapeutic target in cutaneous melanoma - Gembarska A, Luciani F, Fedele C, Russell EA, Dewaele M, Villar S, Zwolinska A, Haupt S, de Lange J, Yip D, Goydos J, Haigh JJ, Haupt Y, Larue L, Jochemsen A, Shi H, Moriceau G, Lo RS, Ghanem G, Shackleton M, Bernal F, Marine JC - 2012 - Nat Med - Pubmed